Tivic Health Systems (Tivic Health Systems) Cash-to-Debt : 9.20 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Tivic Health Systems Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Tivic Health Systems's cash to debt ratio for the quarter that ended in Dec. 2023 was 9.20.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Tivic Health Systems could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Tivic Health Systems's Cash-to-Debt or its related term are showing as below:

TIVC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.71 Med: 9.2 Max: No Debt
Current: 9.2

During the past 5 years, Tivic Health Systems's highest Cash to Debt Ratio was No Debt. The lowest was 0.71. And the median was 9.20.

TIVC's Cash-to-Debt is ranked better than
71.63% of 860 companies
in the Medical Devices & Instruments industry
Industry Median: 1.875 vs TIVC: 9.20

Tivic Health Systems Cash-to-Debt Historical Data

The historical data trend for Tivic Health Systems's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Tivic Health Systems Cash-to-Debt Chart

Tivic Health Systems Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

No Debt

0.71

18.33

6.64

9.20

Tivic Health Systems Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial										6.64	10.23	5.78	12.46	9.20

Competitive Comparison of Tivic Health Systems's Cash-to-Debt

For the Medical Devices subindustry, Tivic Health Systems's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tivic Health Systems's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tivic Health Systems's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Tivic Health Systems's Cash-to-Debt falls into.

Tivic Health Systems Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Tivic Health Systems's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	3.395	/	(0.193	+	0.176)
	=	9.20

Tivic Health Systems's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	3.395	/	(0.193	+	0.176)
	=	9.20

Tivic Health Systems (NAS:TIVC) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Tivic Health Systems Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Tivic Health Systems's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Tivic Health Systems (Tivic Health Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tivic Health Systems Inc (NAS:TIVC) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

25821 Industrial Boulevard, Suite 100, Hayward, CA, USA, 94545

Website

https://www.tivichealth.com

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

Executives

Sheryle Bolton	director	55 ALMADEN BLVD, SAN JOSE CA 95113
Dean Zikria	director	C/O INTUITY MEDICAL, INC., 3500 WEST WARREN AVENUE, FREMONT CA 94538
Jennifer Ernst	director, officer: Chief Executive Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Blake Gurfein	officer: Chief Scientific Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Ryan Sabia	officer: Chief Operating Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Kimberly Ann Bambach	officer: Interim CFO	25821 INDUSTRIAL BLVD., SUITE 100, HAYWARD CA 94545
Karen Drexler	director	C/O DIADEXUS, INC., 343 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Veronica Cai	officer: Chief Financial Officer	C/O CATALYST BIOSCIENCES, INC., 611 GATEWAY BOULEVARD, SUITE 710, SOUTH SAN FRANCISCO CA 94080
John Claude	10 percent owner	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025
Briana Benz	officer: Chief Financial Officer	750 MENLO AVENUE, SUITE 200, MENLO PARK CA 94025